← All patents

US12077760B2

DNA aptamers and use thereof for the treatment of cancer

University of Texas System

Abstract

Provided herein are DNA aptamers targeting AXL receptor kinase. The DNA aptamers may comprise a thiophosphate backbone and be chemically modified. Further provided herein are methods of use thereof for the treatment of a disease or disorder, such as cancer.

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Gabriel Lopez-Berestein
Priority date
December 14, 2018
Filing date
December 16, 2019
Grant date
September 03, 2024
Publication date
September 03, 2024
Language
en
Metadata fetched
August 29, 2026 00:32